Skip to content

Discontinued — last reported Q2 '23

Debt-to-equity at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
0.0×
Viatris logo
ViatrisVTRS
+0.1×
PTH
Pelthos Therapeutics Inc.PTHS
0.8×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.2×+0.1×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-1.5×
Opko Health logo
Opko HealthOPK
0.0×

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.4%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Current ratio0.1×0.0×

Where this comes from

Calculated from Scilex Holding Company’s reported figures.

Based on the most recent quarter.

The official record: Scilex Holding Company’s 10-Q, filed August 11, 2023, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's debt-to-equity?
Scilex Holding Company (SCLX) reported debt-to-equity of 0.3× in Q2 2023.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.